X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (378) 378
Publication (25) 25
Book Review (14) 14
Book Chapter (8) 8
Magazine Article (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tnf-α inhibitors (169) 169
humans (168) 168
index medicus (156) 156
tumor necrosis factor-alpha - antagonists & inhibitors (115) 115
tnf-α inhibitor (100) 100
infliximab (98) 98
tnf-alpha inhibitors (97) 97
rheumatoid arthritis (91) 91
adalimumab (87) 87
etanercept (83) 83
female (83) 83
male (78) 78
rheumatology (65) 65
adult (59) 59
middle aged (57) 57
arthritis, rheumatoid - drug therapy (53) 53
rheumatoid-arthritis (53) 53
antirheumatic agents - therapeutic use (52) 52
tnf-alpha inhibitor (52) 52
tnfα inhibitors (51) 51
treatment outcome (49) 49
antibodies, monoclonal - therapeutic use (45) 45
therapy (43) 43
double-blind (37) 37
aged (36) 36
immunology (35) 35
necrosis-factor-alpha (33) 33
pharmacology & pharmacy (33) 33
medicine & public health (32) 32
efficacy (30) 30
methotrexate (30) 30
psoriasis (30) 30
ankylosing spondylitis (29) 29
arthritis (28) 28
safety (27) 27
inflammation (26) 26
tumor necrosis factor (25) 25
tumor-necrosis-factor (25) 25
animals (24) 24
crohns-disease (24) 24
antirheumatic agents - adverse effects (23) 23
tnf-alpha (23) 23
care and treatment (22) 22
immunoglobulin g - therapeutic use (22) 22
internal medicine (22) 22
monoclonal-antibody (22) 22
receptors, tumor necrosis factor - therapeutic use (22) 22
tnf alpha inhibitors (22) 22
antibodies, monoclonal - adverse effects (20) 20
disease (20) 20
psoriatic arthritis (20) 20
severity of illness index (20) 20
dermatology (19) 19
rheumatoid factor (19) 19
anti-inflammatory agents - therapeutic use (18) 18
certolizumab pegol (18) 18
drug therapy, combination (18) 18
tumor necrosis factor-tnf (18) 18
antibodies, monoclonal, humanized (17) 17
antibodies, monoclonal, humanized - therapeutic use (17) 17
biologics (17) 17
tnf-α (17) 17
tuberculosis (17) 17
monoclonal antibodies (16) 16
analysis (14) 14
drug therapy (14) 14
tnfα inhibitor (14) 14
abridged index medicus (13) 13
ankylosing-spondylitis (13) 13
arthritis, psoriatic - drug therapy (13) 13
cytokines (13) 13
golimumab (13) 13
inhibitors (13) 13
patients (13) 13
placebo-controlled trial (13) 13
rituximab (13) 13
crohn's disease (12) 12
follow-up studies (12) 12
health aspects (12) 12
immunosuppressive agents - therapeutic use (12) 12
inflammatory bowel disease (12) 12
mice (12) 12
retrospective studies (12) 12
risk (12) 12
risk factors (12) 12
spondylitis, ankylosing - drug therapy (12) 12
tumor necrosis factor-alpha - immunology (12) 12
tumor necrosis factor-α (12) 12
arthritis, rheumatoid - immunology (11) 11
immunoglobulin g - adverse effects (11) 11
infections (11) 11
inflammatory-bowel-disease (11) 11
review (11) 11
surgery (11) 11
adalimumab - therapeutic use (10) 10
adolescent (10) 10
anti-inflammatory agents - adverse effects (10) 10
antitumor necrosis factor (10) 10
chemistry, medicinal (10) 10
corticosteroids (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (322) 322
Korean (14) 14
German (12) 12
French (9) 9
Japanese (8) 8
Czech (4) 4
Italian (4) 4
Polish (4) 4
Russian (4) 4
Chinese (3) 3
Dutch (2) 2
Hungarian (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 03/2019, Volume 68, Issue 6, pp. 1024 - 1030
Abstract Background Tumor necrosis factor α inhibitors (TNFi) are commonly used to treat immune-mediated disorders, but they are associated with an increased... 
biologic drugs | TNFα inhibitors | coccidioidomycosis
Journal Article
International journal of oral and maxillofacial surgery, ISSN 0901-5027, 08/2019
Previous reports have suggested a possible association between tumour necrosis factor alpha (TNF-α) inhibitors, used in the treatment of immune-mediated... 
Journal Article
Nauchno-Prakticheskaya Revmatologiya, ISSN 1995-4484, 2018, Volume 56, Issue 3, pp. 333 - 338
Certolizumab pegol (CZP) is the only pegylated biological agent (BA) that does not contain an Fc fragment, which minimizes its transplacental transfer.... 
Certolizumab pegol | Takayasu arteritis | TNF-α inhibitors
Journal Article
Best Practice and Research: Clinical Rheumatology, ISSN 1521-6942, 2014, Volume 28, Issue 2, pp. 293 - 313
The treatment of juvenile idiopathic arthritis (JIA) has substantially evolved over the past two decades. Research has been conducted and is ongoing on how... 
Treatment strategy | DMARD | Biologic | Juvenile idiopathic arthritis | TNF-α inhibitors
Journal Article
British Journal of Oral and Maxillofacial Surgery, ISSN 0266-4356, 10/2019
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 02/2018, Volume 35, Issue 2
Purpose: To measure aggregate and particle formation in tumor necrosis factor-alpha (TNF-α) inhibitors etanercept, adalimumab and certolizumab pegol product... 
Biotechnology | drug product characterization | home storage | Pharmaceutical Science | Pharmacology (medical) | Molecular Medicine | Pharmacology | aggregation of antibodies | freezing stress conditions | TNF-α inhibitors | Organic Chemistry
Journal Article
by Chen, J and Luo, Y and Zhao, MZ and Wu, D and Yang, YJ and Zhang, W and Shen, M
ARTHRITIS RESEARCH & THERAPY, ISSN 1478-6354, 11/2019, Volume 21, Issue 1, pp. 1 - 7
ObjectivesBlau syndrome (BS) is a rare dominantly inherited autoinflammatory disorder associated with mutations in the nucleotide-binding oligomerization... 
RASH | DE-NOVO MUTATION | ADALIMUMAB | IRITIS | RHEUMATOLOGY | Systemic autoinflammatory diseases | TNF alpha inhibitors | FAMILIAL GRANULOMATOUS ARTHRITIS | Nucleotide-binding oligomerization domain | Blau syndrome | DISEASE | UVEITIS | TERM-FOLLOW-UP | INFLIXIMAB | ONSET SARCOIDOSIS | TNFα inhibitors
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 10/2015, Volume 80, Issue 4, pp. 727 - 739
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 11/2017, Volume 77, Issue 5, pp. 845 - 854.e5
Journal Article
Journal of Computational and Theoretical Nanoscience, ISSN 1546-1955, 11/2017, Volume 14, Issue 11, pp. 5278 - 5285
The 3β-acetoxy-18β-olean-10,12-diene-28-oic acid (28 → 21β) lactone 7 had been prepared from oleanolic acid via different chemical alterations'. The lactone 7... 
Anilides | TNF-α Inhibitors | Lactone | Phenolic Esters | Oleanolic Acid | Esters | Inhibitors
Journal Article
Ocular Immunology and Inflammation, ISSN 0927-3948, 2018, pp. 1 - 11
To report the epidemiology, etiology, ocular characteristics, treatment and visual outcome of pediatric uveitis in Israel. Retrospective study from two... 
anterior uveitis | corticosteroids | children | uveitis complications | panuveitis | Adolescents | uveitis | intermediate uveitis | posterior uveitis | TNF-α inhibitors
Journal Article
Infectious Diseases in Clinical Practice, ISSN 1056-9103, 09/2016, Volume 24, Issue 5, pp. 261 - 265
ABSTRACTSince their introduction in the late 1990s, tumor necrosis factor (TNF)-α inhibitors have proven effective in the treatment of several inflammatory... 
disseminated histoplasmosis | fungal infection | immunocompromised host | TNF-α inhibitors
Journal Article
Therapeutic Advances in Gastroenterology, ISSN 1756-283X, 2011, Volume 4, Issue 6, pp. 375 - 389
In this article we provide a contemporary overview of available clinical data on certolizumab pegol, a pegylated anti-tumor necrosis factor (TNF) alpha agent... 
Anti-TNF | certolizumab pegol | Crohn's disease | TNFα inhibitors | Crohns disease
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2017, Volume 16, Issue 6, pp. 564 - 575
Abstract Background Monoclonal antibodies drugs directed against TNFα, TNFα inhibitors, are immunogenic, and consequent anti-drug antibodies (ADA) formation... 
Allergy and Immunology | Immunogenicity | TNFα inhibitors | Anti-drug antibodies | Meta-analysis | RHEUMATOID-ARTHRITIS | CROHNS-DISEASE | ANKYLOSING-SPONDYLITIS | IMMUNOLOGY | BOWEL-DISEASE | ANTI-ADALIMUMAB ANTIBODIES | TNF alpha inhibitors | SERUM TROUGH LEVELS | NECROSIS-FACTOR INHIBITORS | BIOLOGICAL THERAPIES | LONG-TERM TREATMENT | CLINICAL-RESPONSE
Journal Article